Scytovirins and related conjugates, fusion proteins, nucleic...

Details Scytovirins and related conjugates, fusion proteins, nucleic... Scytovirins and related conjugates, fusion proteins, nucleic...

2003-05-15

2009-02-17

Lucas, Zachariah (Department: 1648)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C514S002600, C435S325000, C435S243000, C435S252100, C435S254200, C435S320100, C536S023100, C536S023700

Reexamination Certificate

active

07491798

ABSTRACT:
An isolated or purified antiviral protein of SEQ ID NO: 1, nucleic acids encoding the antiviral protein, cells comprising the nucleic acids, and methods of inhibiting viral infection comprising contacting the virus with the antiviral protein.

REFERENCES:
patent: 5314995 (1994-05-01), Fell, Jr. et al.
patent: 5821081 (1998-10-01), Boyd et al.
patent: 5843882 (1998-12-01), Boyd et al.
patent: 5962653 (1999-10-01), Boyd et al.
patent: 5962668 (1999-10-01), Boyd et al.
patent: 5998587 (1999-12-01), Boyd et al.
patent: 6015876 (2000-01-01), Boyd
patent: 6183961 (2001-02-01), Bernstein et al.
patent: 6193982 (2001-02-01), Boyd
patent: 6245737 (2001-06-01), Boyd et al.
patent: 6428790 (2002-08-01), Boyd
patent: WO 93/06216 (1993-04-01), None
Gait et al., “Progress in anti-HIV structure-based drug design,” Trends in Biotechnology, vol. 13 No. 10, pp. 430-438 (Oct. 1995).
Marcus et al., “HIV: epidemiology and strategies for therapy and vaccination,” Intervirology, vol. 45 No. 4-6, pp. 260-266 (Jul.-Dec. 2002).
Molla et al., “Evolving therapeutic paradigms for HIV and HCV,”Current Opinion in Biotechnology, vol. 14 No. 6, pp. 634-640 (Dec. 2003).
Berkley et al., “Scientific and policy challenges to development of an AIDS vaccine,” The Lancet, vol. 370 No. 9581, pp. 94-101 (Jul. 2007).
McFeeters et al., “The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors,” Journal of Molecular Biology, vol. 369 No. 2, pp. 451-461 (Mar. 2007).
Ziolkowska et al., “Structural studies of algal lectins with anti-HIV activity,” Acta biochimica Polonica, vol. 53 No. 4, pp. 617-626 (Nov. 2006).
Agnew et al.,Sex. Trans. Dis., 22(5), 269-273 (1995).
Amon et al.,The Plant Cell, 10, 781-789 (1998).
Andorfer et al.,J. Insect Phys., 46, 365-372 (2000).
Andreu et al.,J. Infect. Dis., 171, 1237-1243 (1995).
Aullo et al.,EMBO J., 11(2), 575-583 (1992).
Balzarini et al.,Antiviral Res., 18, 191-207 (1992).
Berzofsky,J. Acquired Immune Deficiency Syndromes, 4, 451-459 (1991).
Bolmstedt et al.,Mol. Pharmacology, 59(5), 949-954 (2001).
Boyd et al.,Antimicrob. Agents Chemother., 41(7), 1521-1530 (1997).
Boyd,AIDS Etiology, Diagnosis, Treatment, and Prevention, 2ndEd., 305-317 (1988).
Boyd et al.,J. Med. Chem., 37, 1740-1745 (1994).
Bruce et al.,Can. J. Microbiol., 34, 339-343 (1988).
Buckheit et al.,Antiviral Res., 21, 247-265 (1993).
Cammack,Curr. Opin. Infect. Dis., 14, 13-16 (2001).
Capon et al.,Annu. Rev. Immunol., 9, 649-678 (1991).
Capon et al.,Nature, 337, 525-531 (1989).
Carone et al.,J. Lab. Clin. Med., 100(1), 1-14 (1982).
Carter et al.,J. Org. Chem., 49, 236-241 (1984).
Charan et al.,J. Nat. Prod., 63, 1170-1174 (2000).
Chaudhary et al.,The Human Retroviruses, Ch. 18, 379-387 (1991).
Chaudhary et al.,Nature, 335, 369-372 (1988).
Clanton et al.,J. Acquired Immuned Deficiency Syndromes, 5, 771-781 (1992).
Coffin,Science, 267, 483-489 (1995).
Cohen,Science, 267, 179 (1995).
Cresswell et al.,Algal and Cyanobacterial Biotechnology, 211-218 (1989).
Davey et al.,J. Infect. Dis., 170, 1180-1188 (1994).
Davis,J. Pharm. Pharmacol., 44(Suppl. 1), 186-190 (1992).
De Clercq,Adv. In Virus Res., 42, 1-55 (1993).
De Clercq,J. Acquired Immune Deficiency Syndromes, 4(3), 207-218 (1991).
Does et al.,Plant Mol. Biol., 39, 335-347 (1999).
Dorsey et al.,Protease Inhibitors in AIDS Therapy, Ch. 4, 65-84, no date available.
Duncan et al.,Protease Inhibitors in AIDS Therapy, Ch. 2, 27-48, no date available.
Elmer et al.,JAMA, 275(11), 870-876 (1996).
Faulkner,Nat. Prod. Rep., 355-394 (1994).
Flint et al.,Virlogy Molecular Biology, Pathogenesis, and Control, Ch. 19, 662-714 (2000).
Frankmolle et al.,J. Antibiotics, 45(9), 1451-1457 (1992).
Freed et al.,Bull. Inst. Pasteur., 88, 73-110 (1990).
Fung et al.,J. Immunology, 145(7), 2199-2206 (1990).
Gartner et al.,Techniques in HIV Research, Ch. 3, 59-63 (1994).
Gulakowski et al.,J. Virol. Methods, 33, 87-100 (1991).
Gustafson et al.,J. Med. Chem., 35, 1978-1986 (1992).
Harata et al.,J. Mol. Biol., 297, 673-681 (2000).
Hilier et al.,Clin. Infect. Dis., 16(Suppl 4), S273-S281 (1993).
Hols et al.,Appl. and Environ. Microbiol., 60(5), 1401-1413 (1994).
Husson et al.,J. Pediatr.,121(4), 627-633 (1992).
Kashman et al.,J. Med. Chem.,35, 2735-2743 (1992).
Kemptf,Protease Inhibitors in AIDS Therapy, Ch. 3, 49-64, no date available.
Kilby et al.,Nature Medicine, 4(11), 1302-1307 (1998).
Krishnamurthy et al.,PNAS USA, 86, 770-774 (1989).
Langner et al.,Arch. Virol., 130, 157-170 (1993).
Lifson et al.,J. Exp. Med., 164, 2101-2106 (1986).
Lin et al.,Animicrob Agents Chemother., 33(12), 2149-2151 (1989).
Liou et al.,Biochemistry, 38, 11415-11424 (1999).
Lipton,Nature, 367, 113-114 (1994).
Matsushita et al.,J. Virology, 62(6), 2107-2114 (1988).
McGroarty,FEMS Immunol. Med. Microbiol., 6, 251-264 (1993).
Merigan,Amer. J. Med., 90(Suppl. 4A), 8S-17S (1991).
Michalowski et al.,Nucleic Acids Res., 18(8), 2186 (1990).
Mitsuya et al.,Science, 249, 1533-1544 (1990).
Moore et al.,J. Virology, 66(1), 235-243 (1992).
Morgan et al.,AIDS Research and Human Retroviruses, 10(11), 1507-1515 (1994).
Okino et al.,Tetrahedron Ltrs., 34(3), 501-504 (1993).
Orloff et al.,AIDS Research and Human Retroviruses, 11(3), 335-342 (1995).
Patterson et al.,J. Phycol., 27, 530-536 (1991).
Patterson et al.,J. Phycol., 29, 125-130 (1993).
Polsky et al.,Contraception, 39(6), 579-587 (1989).
Ramachandran et al.,JID, 170, 1009-1013 (1994).
Redondo-Lopez et al.,Reviews Infect. Dis., 12(5), 856-872 (1990).
Reich,Protease Inhibitors in AIDS Therapy, Ch. 5, 85-99, no date available.
Reid et al.,Clinical Microbiol. Reviews, 3(4), 335-344 (1990).
Rosenberg et al.,Amer. J. Pub. Health, 82(11), 1473-1478 (1992).
Rosenberg et al.,Sexually Transmitted Diseases, 20(1), 41-44 (1993).
Royer et al.,Pharmacol. Res., 24(4), 407-412 (1991).
Rumbeli et al.,FEBS Ltrs., 221(1), 1-2 (1987).
Sattentau et al.,AIDS, 2(2), 101-105 (1988).
Schaeffer et al.,Ecotoxicology and Evironmental Safety, 45, 208-227 (2000).
Schooley et al.,Annals of Internal Medicine, 112(4), 247-253 (1990).
Shenoy et al.,J. Pharmacol. Exp. Ther.,297(2), 704-710 (2001).
Sherman et al.,The Cyanobacteria, Ch. 1, 1-33 (1987).
Shih et al.,PNAS USA, 88, 9878-9882 (1991).
Sivonen et al.,Chem. Res. Toxicol., 5(4), 464-469 (1992).
Suter et al.,FEBS Ltrs., 217(2), 279-282 (1987).
Swanson et al.,J. Biol. Chem., 267(23) 16146-16154 (1992).
Taylor,J. NIH Res., 6, 26-27 (1994).
Theiβ et al.,Meth. Find. Exp. Clin. Pharmacol., 13(5), 353-359 (1991).
Till et al.,Science, 242, 1166-1168 (1988).
Traunecker et al.,Nature, 339, 68-70 (1989).
Tung et al.,Protease Inhibitors in AIDS Therapy, Ch. 6, 101-118, no date available.
Verhoef et al.,Eur. J. Drug Metab. Phartmacokinet., 15(2), 83-93 (1990).
Wallace et al.,Science, 260, 912-913 (1993).
Weislow et al.,J. Natl. Cancer Inst., 81(8), 577-586 (1989).
White et al.,Antiviral Res., 16, 257-266 (1991).
Wunsch,Biopolymers, 22, 493-505 (1983).
Yeh et al.,PNAS USA, 89, 1904-1908 (1992).
Zaghouani et al., PNAS USA, vol. 88, 5645-5649 (1991).
Bokesch et al.,Biochemistry, 42:2578-2584 (2003).
Gustafson et al.,Biochemical and Biophysical Research Communications, 238(No. 1):223-228 (1997).
Adams et al., “Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions,”Chem. Biol., 11, 875-881 (2004).
Bewley et al., “Solution structure of cyanovirin-N, a potent HIV-inactivating protein,”Nat. Struct. Biol., 5(7), 571-578 (1998).
Botos et al., “Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides,”J. Biol. Chem., 277(37), 34336-34342 (2002).
McFeeters et al., “The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors,”J. Mol. Biol., 369, 451-461 (2007).
Xiong et al., “Potent anti-HIV activity of scytovirin domain 1 peptide,”Peptides, 27, 1668-1675 (2006).

Affiliated with

Also associated with

Rating

Scytovirins and related conjugates, fusion proteins, nucleic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Scytovirins and related conjugates, fusion proteins, nucleic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Scytovirins and related conjugates, fusion proteins, nucleic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4071525